Bioreductive activation of a series of analogues of 5-aziridinyl-3-hydroxymethyl-1-methyl-2-[1H-indole-4, 7-dione] prop-beta-en-alpha-ol (EO9) by human DT-diaphorase (Q41145264)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 1996

Language	Label	Description	Also known as
English	Bioreductive activation of a series of analogues of 5-aziridinyl-3-hydroxymethyl-1-methyl-2-[1H-indole-4, 7-dione] prop-beta-en-alpha-ol (EO9) by human DT-diaphorase	scientific article published on December 1996

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Bioreductive activation of a series of analogues of 5-aziridinyl-3-hydroxymethyl-1-methyl-2-[1H-indole-4, 7-dione] prop-beta-en-alpha-ol (EO9) by human DT-diaphorase (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

author name string

Phillips RM

1

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

language of work or name

0 references

publication date

1 December 1996

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

1711-1718

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

DT-diaphorase as a quinone reductase: a cellular control device against semiquinone and superoxide radical formation

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

Cytosolic NAD(P)H:(quinone-acceptor)oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

DT-diaphorase activity in normal and neoplastic human tissues; an indicator for sensitivity to bioreductive agents?

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

DT-diaphorase and cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

The Role of NAD(P)H: Quinone Reductase (EC 1.6.99.2, DT-Diaphorase) in the Reductive Bioactivation of the Novel Indoloquinone Antitumor Agent E09

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

Factors affecting sensitivity to EO9 in rodent and human tumour cells in vitro: DT-diaphorase activity and hypoxia

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

Chemosensitivity to the indoloquinone EO9 is correlated with DT-diaphorase activity and its gene expression

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

EO9: relationship between DT-diaphorase levels and response in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9.

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

EO9: a novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

Phase I and pharmacologic study of the novel indoloquinone bioreductive alkylating cytotoxic drug E09.

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

The experimental development of bioreductive drugs and their role in cancer therapy.

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

Cytotoxic effects of anticancer agents on subconfluent and multilayered postconfluent cultures

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

Expression of rat liver NAD(P)H:quinone-acceptor oxidoreductase in Escherichia coli and mutagenesis in vitro at Arg-177

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

Purification by cibacron blue F3GA dye affinity chromatography and comparison of NAD(P)H:quinone reductase (E.C.1.6.99.2) from rat liver cytosol and microsomes

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

An agarose gel method for the determination of DNA interstrand crosslinking applicable to the measurement of the rate of total and "second-arm" crosslink reactions

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

Alteration in DNA cross-linking and sequence selectivity of a series of aziridinylbenzoquinones after enzymatic reduction by DT-diaphorase

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

In vitro activity of the novel indoloquinone EO-9 and the influence of pH on cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

Indoloquinone EO9: DNA interstrand cross-linking upon reduction by DT-diaphorase or xanthine oxidase

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

The differences in kinetics of rat and human DT diaphorase result in a differential sensitivity of derived cell lines to CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide)

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

The autoxidation of the reduced forms of EO9

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

DT-diaphorase protects cells from the hypoxic cytotoxicity of indoloquinone EO9.

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

Structure-activity relationships for DT-diaphorase reduction of hypoxic cell directed agents: indoloquinones and diaziridinyl benzoquinones

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

The role of human and rodent DT-diaphorase in the reductive metabolism of hypoxic cell cytotoxins.

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(96)00521-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-2952(96)00521-7

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41145264&oldid=2269814394"